Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HFSA 25: 96-week Analysis from FOREST-HCM
Author(s): Ahmad Masri Added: 6 months ago
HFSA 25 - Aficamten found to significantly improve NYHA and KCCQ-CSS scores in new 96-week data from FOREST-HCM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss findings from the FOREST-HCM trial, examining the sustained safety and efficacy of aficamten in patients with symptomatic nonobstructive hypertrophic cardiomyopathy.This phase 2 open-label study followed 34… View more

Heart Failure
Recognising Undiagnosed Heart Failure in Women
Author(s): Renate B Schnabel , Eva Gerdts , Added: 7 months ago
Cardiovascular disease in women is frequently underdiagnosed, with heart failure often overlooked due to subtle symptoms and persistent clinical bias. In this on-demand symposium, leading experts explore why cardiovascular disease is missed in women, the unique risks and presentations of female heart failure and how early detection of atrial fibrillation can improve outcomes. Chaired by Prof… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
Autoimmune Disorders and Cardiomyopathy with Dr Heba Wassif
Author(s): Heba Wassif Added: 4 months ago
Navigate the diagnostic and therapeutic landscape of autoimmune disorders and cardiomyopathy with Dr Heba WassifThis presentation, part of the comprehensive Cardiomyopathies track, explores the critical intersection between immune-mediated inflammatory disorders and cardiovascular disease.Dr Wassif examines the spectrum and epidemiology of immune-mediated inflammatory disorders, emphasizing their… View more

Heart Failure
Precision in Practice: Navigating Amyloidosis Diagnosis and Referral
Author(s): Margot K Davis , , , et al Added: 11 months ago
In this symposium, filmed at HFA 2025 (Belgrade, RS), moderator Dr Margot Davis (Vancouver, CA) is joined by Prof Fabian Knebel (Berlin, DE), Dr AleksandarAleksandrov (Berlin, DE) and Prof Olivier Lairez (Toulouse, FR) to unpack a recent, real-life patient referral. The faculty explore the challenges faced during the referral process and then evaluate the practical steps for making a confident… View more

Heart Failure
Challenges in ATTR Amyloidosis: An Expert Debate
Author(s): Ahmad Masri , Ahmad Masri , Thibaud Damy , et al Added: 1 year ago
Radcliffe Medical Education bring together a globally-renowed faculty, including Prof Thibaud Damy (Creteil, FR) as he chairs a panel of distinguished experts, Dr Esther González López (Madrid, SP), Dr João R. Agostinho (Lisbon, PT) and Dr Ahmad Masri (Portland, USA) in a interactive symposium centred around three distinctive challenges facing physicians when diagnosing and treating ATTR-CM… View more

Heart Failure
Transcatheter Solutions for the Treatment of Mitral and Tricuspid Disease
Author(s): Robert Cubeddu, MD , Dee Dee Wang , Viviana Navas, MD Added: 1 year ago
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Explore case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients. View more

Intervention

Guidelines & Statements
Mavacamten Reduces Biomarkers in nHCM: ODYSSEY-HCM Data
Added: 3 months ago Source:  Radcliffe Cardiology
An exploratory analysis of the ODYSSEY-HCM trial has shown that mavacamten significantly reduces key cardiac biomarkers in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM), a condition with no approved therapies.¹ While the main trial did not meet its primary endpoints of improving functional capacity or patient-reported health status, these biomarker findings suggest a… View more

Heart Failure
CMR Tracks ATTR-CM Progression and Treatment Response
Added: 4 months ago Source:  Radcliffe Cardiology
Cardiovascular magnetic resonance (CMR) with extracellular volume (ECV) mapping can effectively track changes in cardiac amyloid burden in transthyretin amyloid cardiomyopathy (ATTR-CM) and is independently associated with patient outcomes, according to a new prospective study.¹This single-centre prospective study included 189 patients with ATTR-CM. The cohort was divided into an untreated group … View more

Imaging & Diagnostics

Heart Failure
Heart Disease in Pregnancy: Maternal and Neonatal Risk
Author(s): Rofila Dita Karmia , Mefri Yanni , Yusrawati , et al Added: 3 months ago

Inherited and Congenital Cardiac Conditions

Electrophysiology & Arrhythmia
Comparison of Haemodynamic Responses to Landiolol Versus Esmolol
Author(s): Georgios Koukoulitsios , Kyriaki Tsikritsaki , Georgios Magklaras , et al Added: 10 months ago

Vascular Disease and Surgery

Heart Failure